Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
Angina
Chronic coronary syndrome
Coronary artery disease
Myocardial infarction
Journal
European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263
Informations de publication
Date de publication:
14 01 2020
14 01 2020
Historique:
received:
06
08
2019
revised:
19
08
2019
accepted:
28
08
2019
pubmed:
11
9
2019
medline:
4
3
2021
entrez:
11
9
2019
Statut:
ppublish
Résumé
Over the last decades, the profile of chronic coronary syndrome has changed substantially. We aimed to determine characteristics and management of patients with chronic coronary syndrome in the contemporary era, as well as outcomes and their determinants. Data from 32 703 patients (45 countries) with chronic coronary syndrome enrolled in the prospective observational CLARIFY registry (November 2009 to June 2010) with a 5-year follow-up, were analysed. The primary outcome [cardiovascular death or non-fatal myocardial infarction (MI)] 5-year rate was 8.0% [95% confidence interval (CI) 7.7-8.3] overall [male 8.1% (7.8-8.5); female 7.6% (7.0-8.3)]. A cox proportional hazards model showed that the main independent predictors of the primary outcome were prior hospitalization for heart failure, current smoking, atrial fibrillation, living in Central/South America, prior MI, prior stroke, diabetes, current angina, and peripheral artery disease. There was an interaction between angina and prior MI (P = 0.0016); among patients with prior MI, angina was associated with a higher primary event rate [11.8% (95% CI 10.9-12.9) vs. 8.2% (95% CI 7.8-8.7) in patients with no angina, P < 0.001], whereas among patients without prior MI, event rates were similar for patients with [6.3% (95% CI 5.4-7.3)] or without angina [6.4% (95% CI 5.9-7.0)], P > 0.99. Prescription rates of evidence-based secondary prevention therapies were high. This description of the spectrum of chronic coronary syndrome patients shows that, despite high rates of prescription of evidence-based therapies, patients with both angina and prior MI are an easily identifiable high-risk group who may deserve intensive treatment. ISRCTN43070564.
Identifiants
pubmed: 31504434
pii: 5556903
doi: 10.1093/eurheartj/ehz660
pmc: PMC6964227
doi:
Banques de données
ISRCTN
['ISRCTN43070564']
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
347-356Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
Lancet. 2005 Jan 1-7;365(9453):82-93
pubmed: 15639683
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
Circulation. 2017 Nov 14;136(20):1908-1919
pubmed: 28844989
Lancet. 2003 Sep 6;362(9386):782-8
pubmed: 13678872
Eur Heart J. 2012 Aug;33(16):2088-97
pubmed: 22511654
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Coron Artery Dis. 2017 Dec;28(8):636-641
pubmed: 28914638
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
Clin Cardiol. 2017 Oct;40(10):797-806
pubmed: 28561986
Lancet. 2001 May 5;357(9266):1385-90
pubmed: 11356434
Lancet. 2009 May 30;373(9678):1849-60
pubmed: 19482214
Am J Cardiol. 1972 Feb;29(2):154-63
pubmed: 5058341
N Engl J Med. 2017 Oct 5;377(14):1319-1330
pubmed: 28844192
JAMA. 2014 Mar 5;311(9):919-28
pubmed: 24595776
Eur Heart J. 2018 Feb 14;39(7):508-579
pubmed: 29190377
Lancet. 2016 Oct 29;388(10056):2142-2152
pubmed: 27590221
J Am Coll Cardiol. 2017 May 2;69(17):2149-2156
pubmed: 28449776
JAMA. 2011 Apr 27;305(16):1677-84
pubmed: 21521849
Circulation. 2019 Jun 18;139(25):e1082-e1143
pubmed: 30586774
Eur Heart J. 2005 May;26(10):996-1010
pubmed: 15778205
JAMA Intern Med. 2014 Oct;174(10):1651-9
pubmed: 25110899
BMJ. 2006 Feb 4;332(7536):262-7
pubmed: 16415069
JAMA. 2012 Sep 12;308(10):998-1006
pubmed: 22928184
Eur Heart J. 2012 Nov;33(22):2831-40
pubmed: 22922505
Circulation. 2014 Nov 4;130(19):1749-67
pubmed: 25070666
N Engl J Med. 2017 May 4;376(18):1713-1722
pubmed: 28304224
Lancet. 1994 Nov 19;344(8934):1383-9
pubmed: 7968073
JAMA. 2010 Sep 22;304(12):1350-7
pubmed: 20805624
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Circulation. 1994 Dec;90(6):2645-57
pubmed: 7994804
JAMA. 2006 Jan 11;295(2):180-9
pubmed: 16403930